This is an antibody developed by antibody phage display technology using a human naive antibody gene library and human serum amyloid A1 antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.
产品特性
This antibody can be detected with anti-mouse Fc secondary antibodies.
纯化方法
Protein A purification
免疫原
No immunization, animal-free antibody development. Antigen: human serum amyloid A1
ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody Optimal working dilution should be determined by the investigator
限制
仅限研究用
状态
Liquid
浓度
1 mg/mL
缓冲液
PBS, pH 7.4,
储存条件
-20 °C
抗原
SAA1
(Serum Amyloid A1 (SAA1))
别名
Serum Amyloid A1
背景
Serum Amyloid A1 (SAA1) is a prominent acute-phase protein in humans, primarily produced by the liver in response to inflammation. It plays a role in the immune system, potentially aiding in tissue repair, acting as an antibacterial agent, and signaling the migration of immune cells to sites of infection. Levels of SAA1 can increase dramatically (up to 1000-fold) during inflammatory states triggered by infections, injury, or chronic diseases.